The Column - February 2007 - (Page 6)

News The Column www.thecolumn.eu.com February 2007 News Product innovation prize Paraytec has been awarded a prize for product innovation at the recent Venturefest Yorkshire awards Yorkshire, UK . The company’s ActiPix detection instrument was judged best innovative new product with high growth potential and the company was presented with the GSPK New Product Award and a prize package of £20 000. The winning instrument is an imaging detector developed for use in analytical and life sciences applications. It is the first product to incorporate the company’s patented miniaturized analytical detection system for liquid samples. The ActiPix D100 uses capillaries the width of a human hair to carry tiny liquid samples through a beam of UV light. It then captures and processes the images using an active pixel sensor, which is similar to the technology used in digital cameras and mobile phones. For more information on this and other instruments available from Paraytec visit the website at www.paraytec.com Manufacturing agreement Novasep and Avexa have signed a manufacturing agreement for the production of apricitabine ATC . This product is Avexa’s novel nucleoside reverse transcriptase inhibitor NRTI that is in clinical development for the treatment of HIV infection. Avexa is a Melbourne-based biotechnology company that focuses on the research and development of drugs for the treatment of infectious diseases. Additionally, it has dedicated resources and funding for key projects including antiviral drugs for HIV/Aids and an antibiotic alternative for antibiotic-resistant bacterial infections. Apricitabine is currently in Phase IIb clinical trials and is the company’s lead programme. The agreement with Novasep covers the continued production, process optimization and further scale-up of the active pharmaceutical ingredient API of ATC based upon Links: 6 GPC/SEC course PSS Polymer Standards Service is providing a training course titled Theory and Practice in Mainz, Germany on 22–23 March. This two-day course will consist of theory lectures and practical sessions for modern analysis of macromolecules using gel permeation chromatography/size exclusion chromatography GPC/SEC . The course will cover the theoretical background of the separation technique, in addition to giving practical advice and showing the application advantages and limitations of GPC/SEC, GPC/SEC–light scattering viscometry and other techniques. In the practice sessions small workgroups five people maximum verify a GPC/SEC system, check the performance of the separation column and calibrate and evaluate samples using different techniques. Each group has its own tutor, an experienced polymer chemist, to discuss special applications and questions. For more information on this course please visit the website at www.polymer.de www.polymer.de www.novasep.com the Varicol continuous chromatography system for use in Phase III clinical trials and in preparation for the commercial launch of the product. For more information please visit the companies’ websites at www.avexa.com.au and www.novasep.com www.paraytec.com www.avexa.com.au http://www.thecolumn.eu.com http://www.paraytec.com http://www.avexa.com.au http://www.novasep.com http://www.polymer.de http://www.paraytec.com http://www.polymer.de http://www.avexa.com.au http://www.novasep.com

Table of Contents for the Digital Edition of The Column - February 2007

Contents
News
Zosimus
Market Trends and Analysis
Biodiesel - The Alternative Fuel
Biodiesel (FAME) Analysis by FT-IR
Tips and Tricks: GPC/SEC
Q&A

The Column - February 2007